Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Medical Device > European Markets for Facial Aesthetics 2008
Category
Medical Device (4386)
Cardiovascular Device (252)
Catheter Equipment (206)
CT and MRI and X ray (146)
Dental Equipment (177)
Disposable Medical Device (83)
Endoscopy Equipment (114)
Healthcare IT (310)
In Vitro Diagnostics Equipment (436)
Medical Imaging (425)
Molecular Imaging/Agents (29)
Nuclear Medical (76)
Ophthalmic Equipment (105)
Orthopedic (343)
Patient Monitoring (384)
Ultra Sound (50)
Wound Care (120)
Market Research Report

European Markets for Facial Aesthetics 2008

Published by Millennium Research Group
Published May, 2008 Product code 72164
Content info  
Price
US $ 4897 PDF by E-mail (Single user license)
US $ 7350 PDF by E-mail (Corporate license)


European Markets for Facial Aesthetics 2008 published by Millennium Research Group in May, 2008. This report price starts from US $ 4897.

Introduction

Abstract

The European facial aesthetic market in France, Germany, Italy, Spain, and the UK achieved double-digit growth over 2006.

This market comprises sales of botulinum toxin, hyaluronic acid, particle and polymer fillers, and collagen injectables.

Table of Contents

1.0 EUROPEAN FACIAL AESTHETIC MARKET

  • 1.1 Market Overview
  • 1.2 Market Analysis
    • 1.2.1 Product Overview
    • 1.2.2 Procedure Forecast
      • 1.2.2.1 Botulinum Toxin Procedures
        • BTX-A Procedures
        • BTX-B Procedures
      • 1.2.2.2 Hyaluronic Acid Procedures
        • Standard Hyaluronic Acid
        • Rejuvenation Hyaluronic Acid
      • 1.2.2.3 Particle and Polymer Filler Procedures
      • 1.2.2.4 Collagen Procedures
    • 1.2.3 Market Forecast
      • 1.2.3.1 French Facial Aesthetic Market
      • 1.2.3.2 German Facial Aesthetic Market
      • 1.2.3.3 Italian Facial Aesthetic Market
      • 1.2.3.4 Spanish Facial Aesthetic Market
      • 1.2.3.5 UK Facial Aesthetic Market
      • 1.2.3.6 End-User Insights
    • 1.2.4 Market Drivers and Limiters
      • 1.2.4.1 Market Drivers
      • 1.2.4.2 Market Limiters
  • 1.3 Competitive Analysis
    • 1.3.1 Emerging Competitors
    • 1.3.2 End-User Insights

2.0 BOTULINUM TOXIN MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Product Overview
    • 2.2.2 Market Forecast
      • 2.2.2.1 BTX-A Market
      • 2.2.2.2 BTX-B Market
    • 2.2.3 Market Drivers and Limiters
  • 2.3 Competitive Analysis

3.0 HYALURONIC ACID MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Product Overview
    • 3.2.2 Market Forecast
      • 3.2.2.1 Standard Hyaluronic Acid Market
      • 3.2.2.2 Rejuvenation Hyaluronic Acid Market
    • 3.2.3 Market Drivers and Limiters
  • 3.3 Competitive Analysis

4.0 PARTICLE AND POLYMER FILLER MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Product Overview
    • 4.2.2 Market Forecast
    • 4.2.3 Market Drivers and Limiters
  • 4.3 Competitive Analysis

5.0 COLLAGEN MARKET

  • 5.1 Market Overview
  • 5.2 Market Analysis
    • 5.2.1 Product Overview
    • 5.2.2 Market Forecast
    • 5.2.3 Market Drivers and Limiters
  • 5.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

  • Exhibit 1: Facial Aesthetic Market, Europe (US$), 2006-2012
  • Exhibit 2: BTX Procedures, Europe, 2006-2012
  • Exhibit 3: Standard HA Market and Rejuvenation HA Market, Europe, (US$), 2006-2012
  • Exhibit 4: PPF Market, as a % of Total Facial Aesthetic Market, Europe, 2012
  • Exhibit 5: Collagen Market, by Country, Europe, 2007 and 2012
  • Exhibit 6: Leading Competitors in the Facial Aesthetic Market, Europe, 2007

METHODOLOGY

  • Exhibit 7: Currency Exchange Rates, 2007

CHAPTER 1: EUROPEAN FACIAL AESTHETIC MARKET

  • Exhibit 8: Facial Aesthetic Market, by Country, Europe (US$), 2006-2012
  • Exhibit 9: Common Facial Aesthetic Product Lines and Products, Europe, 2007
  • Exhibit 10: Common Facial Aesthetic Product Lines and Products, Europe, 2007 (Cont' d)
  • Exhibit 11: BTX Procedures, by Country, Europe, 2006-2012
  • Exhibit 12: BTX-A Procedures, by Country, Europe, 2006-2012
  • Exhibit 13: BTX-B Procedures, by Country, Europe, 2006-2012
  • Exhibit 14: HA Procedures, by, Country, Europe, 2006-2012
  • Exhibit 15: Standard HA Procedures, by Country, Europe, 2006-2012
  • Exhibit 16: Rejuvenation HA Procedures, by Country, Europe, 2006-2012
  • Exhibit 17: PPF Procedures, by Country, Europe, 2006-2012
  • Exhibit 18: Collagen Procedures, by Country, Europe, 2006-2012
  • Exhibit 19: Facial Aesthetic Market, by Country, Europe (US$), 2006-2012
  • Exhibit 20: Facial Aesthetic Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 21: Facial Aesthetic Market, by Segment, France (US$), 2006-2012
  • Exhibit 22: Facial Aesthetic Market, by Segment, France (€), 2006-2012
  • Exhibit 23: Facial Aesthetic Market Growth, by Segment, France, 2007-2012
  • Exhibit 24: Facial Aesthetic Market, by Segment, Germany (US$), 2006-2012
  • Exhibit 25: Facial Aesthetic Market, by Segment, Germany (€), 2006-2012
  • Exhibit 26: Facial Aesthetic Market Growth, by Segment, Germany, 2007-2012
  • Exhibit 27: Facial Aesthetic Market, by Segment, Italy (US$), 2006-2012
  • Exhibit 28: Facial Aesthetic Market, by Segment, Italy (€), 2006-2012
  • Exhibit 29: Facial Aesthetic Market Growth, by Segment, Italy, 2007-2012
  • Exhibit 30: Facial Aesthetic Market, by Segment, Spain (US$), 2006-2012
  • Exhibit 31: Facial Aesthetic Market, by Segment, Spain (€), 2006-2012
  • Exhibit 32: Facial Aesthetic Market Growth, by Segment, Spain, 2007-2012
  • Exhibit 33: Facial Aesthetic Market, by Segment, UK (US$), 2006-2012
  • Exhibit 34: Facial Aesthetic Market, by Segment, UK (£), 2006-2012
  • Exhibit 35: Facial Aesthetic Market Growth, by Segment, UK, 2007-2012
  • Exhibit 36: Factors Influencing Product Adoption, Europe, 2007
  • Exhibit 37: Drivers and Limiters of the Facial Aesthetic Market, Europe
  • Exhibit 38: Leading Competitors in the Facial Aesthetic Market, by Country, as a % of Total, Europe, 2007

CHAPTER 2: BOTULINUM TOXIN MARKET

  • Exhibit 39: BTX Market, by Country, Europe, (US$), 2006-2012
  • Exhibit 40: Common BTX Products, Europe, 2007
  • Exhibit 41: BTX Market, by Country, Europe (US$), 2006-2012
  • Exhibit 42: BTX Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 43: BTX-A Market, by Country, Europe (US$), 2006-2012
  • Exhibit 44: BTX-A Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 45: BTX-A Market Growth, by Country, Europe, 2007-2012
  • Exhibit 46: BTX-B Market, by Country, Europe (US$), 2006-2012
  • Exhibit 47: BTX-B Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 48: BTX-B Market Growth, by Country, Europe, 2007-2012
  • Exhibit 49 and Exhibit 50 list the drivers and limiters of the BTX market in Europe.
  • Exhibit 49: Drivers of the BTX Market, Europe
  • Exhibit 50: Limiters of the Botulinum Toxin Market, Europe
  • Exhibit 51: Leading Competitors in the Botulinum Toxin Market, by Country, Europe, 2007

CHAPTER 3: HYALURONIC ACID MARKET

  • Exhibit 52: HA Market, by Country, Europe (US$), 2006-2012
  • Exhibit 53: Common Standard Hyaluronic Acid Products/Product Line Overview, Europe, 2007
  • Exhibit 54: Common Standard HA Products/Product Line Overview, Europe, 2007 (Cont' d)
  • Exhibit 55: Common Rejuvenation Hyaluronic Acid, Products/Product Line Overview, Europe, 2007
  • Exhibit 56: HA Market, by Country, Europe (US$), 2006-2012
  • Exhibit 57: Hyaluronic Acid Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 58: Standard HA Market, by Country, Europe (US$), 2006-2012
  • Exhibit 59: Standard Hyaluronic Acid Market, by Country, Europe (€M and £M), 2006-2012
  • Exhibit 60: Standard Hyaluronic Acid Market Growth, by Country, Europe, 2007- 2012
  • Exhibit 61: Rejuvenation HA Market, by Country, Europe (US$), 2006-2012
  • Exhibit 62: Rejuvenation Hyaluronic Acid Market, by Country, Europe (€M and £M), 2006-2012
  • Exhibit 63: Rejuvenation Hyaluronic Acid Market Growth, by Country, Europe, 2007-2012
  • Exhibit 64: Drivers of the Hyaluronic Acid Market, Europe
  • Exhibit 65: Limiters of the Hyaluronic Acid Market
  • Exhibit 66: Leading Competitors in the Hyaluronic Acid Market, by Country, Europe, 2007

CHAPTER 4: PARTICLE AND POLYMER FILLER MARKET

  • Exhibit 67: Particle and Polymer Filler Market, by Country, Europe (US$), 2006- 2012
  • Exhibit 68: Common Particle and Polymer Filler Products, Europe, 2007
  • Exhibit 69: Common Particle and Polymer Filler Products, Europe, 2007 (Cont' d)
  • Exhibit 70: PPF Market, by Country, Europe (US$), 2006-2012
  • Exhibit 71: PPF Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 72: PPF Market Growth, by Country, Europe, 2007-2012
  • Exhibit 73: Drivers of the PPF Market, Europe
  • Exhibit 74: Limiters of the PPF Market, Europe
  • Exhibit 75: Leading Competitors in the Particle and Polymer Filler Market, by Country, Europe, 2007

CHAPTER 5: COLLAGEN MARKET

  • Exhibit 76: Collagen Market, by Country, Europe (US$), 2006-2012
  • Exhibit 77: Collagen Product Overview, Europe, 2007
  • Exhibit 78: Collagen Market, by Country, Europe (US$), 2006-2012
  • Exhibit 79: Collagen Market, by Country, Europe (€ and £), 2006-2012
  • Exhibit 80: Collagen Market Growth, by Country, 2007-2012
  • Exhibit 81: Drivers of the Collagen Market, Europe
  • Exhibit 82: Limiters of the Collagen Market, Europe
  • Exhibit 83: Leading Competitors in the Collagen Market, by Country, as a % of Total, Europe, 2007

MRG ACRONYMS AND INITIALISMS

Back to Top